Enveric Biosciences (ENVB) FCF Margin (2014 - 2020)
Enveric Biosciences (ENVB) posted FCF Margin of 4.71% for Q3 2020, down 11.91% sequentially from 4.21% in Q2 2020.
Enveric Biosciences (ENVB) FCF Margin (2014 - 2020) Analysis & Trends
Enveric Biosciences has reported FCF Margin for 7 years, with the latest figure at 4.71% in Q3 2020.
- Quarterly FCF Margin changed N/A year-over-year to 4.71% in Q3 2020, while the trailing twelve-month figure through Sep 2020 was 2.59% (up 346.0% YoY) and the FY2019 annual result came in at 1.83%, up 412.0% from the prior year.
- FCF Margin slipped to 4.71% in Q3 2020 per ENVB's latest filing, from 4.21% in the prior quarter.
- Over five years, FCF Margin peaked at 8.49% in Q4 2019 and troughed at 24.2% in Q4 2016.
- A 5-year average of 5.24% and a median of 4.74% in 2016 frame the typical range for FCF Margin.
- The widest YoY moves for FCF Margin: up 7836 bps in 2016, down 2972 bps in 2016.
- Over 5 years, FCF Margin stood at 24.2% in 2016, then jumped by 66 bps to 8.19% in 2017, then dropped by 17 bps to 9.58% in 2018, then soared by 189 bps to 8.49% in 2019, then plunged by 156 bps to 4.71% in 2020.
- According to Business Quant data, FCF Margin over the past three periods registered 4.71%, 4.21%, and 9.76% for Q3 2020, Q2 2020, and Q1 2020 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -388.28% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 25.68% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 22.62% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 41.07% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -22.35% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 70.82% |
| 10 | Enveric Biosciences | 5.66 Mn | -2.64 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | -4.71% |
| Jun 30, 2020 | -4.21% |
| Mar 31, 2020 | -9.76% |
| Dec 31, 2019 | 8.49% |
| Jun 30, 2019 | -4.59% |
| Mar 31, 2019 | -9.32% |
| Dec 31, 2018 | -9.58% |
| Sep 30, 2018 | -12.11% |
| Jun 30, 2018 | 1.50% |
| Mar 31, 2018 | -4.15% |
| Dec 31, 2017 | -8.19% |
| Sep 30, 2017 | -0.79% |
| Jun 30, 2017 | -7.01% |
| Mar 31, 2017 | -6.87% |
| Dec 31, 2016 | -24.20% |
| Sep 30, 2016 | 5.57% |
| Jun 30, 2016 | -4.76% |
| Mar 31, 2016 | 0.31% |
| Dec 31, 2015 | 5.52% |
| Sep 30, 2015 | -72.78% |